Trials / Active Not Recruiting
Active Not RecruitingNCT02664701
Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts
Cognitive Behavioural Group Therapy Versus Individual Supportive Therapy for the Prevention of Repeat Suicide Attempts: a Multicentre, Assessor-blinded, 2-parallel-group, Randomised, Superiority Trial
- Status
- Active Not Recruiting
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 240 (estimated)
- Sponsor
- Centre Hospitalier Universitaire de Nīmes · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The primary objective of this study is to evaluate the efficacy of a program of 6 sessions of Cognitive Behavioural Group Therapy (CBGT) (as compared to 6 sessions of Individual Supportive Therapy (IST)) designed for preventing repeat suicide attempts at 12 months post-psychotherapy in adults admitted to inpatient care for suicide attempts.
Detailed description
The secondary objectives of this study are to assess the efficacy of CBGT on: A. parameters describing the incidence of suicide and repeat suicide attempts, as well as suicide re-attempt free follow-up time, B. long-term changes in suicidal ideation, C. long-term changes in psychiatric symptoms (depression, hope for the future, hospitalization).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Baseline evaluation with a psychiatrist | Baseline data and questionnaires are established. |
| OTHER | Individual supportive therapy | 6 sessions of individual supportive therapy with a psychologist, 1 session per week for 6 weeks |
| OTHER | Cognitive behavioural group therapy | 6 sessions of cognitive behavioural group therapy with a psychologist, 1 session per week for 6 weeks |
| OTHER | Evaluations with a psychiatrist | Evaluation withs a psychiatrist in the 10 days following the end of psychotherapy, then at 3, 6, 9, and 12 months. |
Timeline
- Start date
- 2017-10-17
- Primary completion
- 2025-11-01
- Completion
- 2025-11-01
- First posted
- 2016-01-27
- Last updated
- 2025-08-20
Locations
9 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02664701. Inclusion in this directory is not an endorsement.